Tesaglitazar

CAS No.

251565-85-2

MDL No.

MFCD07784004

C₂₀H₂₄O₇S

408.50

InChI Key

CXGTZJYQWSUFET-IBGZPJMESA-N

Pack Size	Purity	Price	Availability
1 mg	≥95%(HPLC)	$60	In Stock
5 mg	≥95%(HPLC)	$171	In Stock
10 mg	99.95% ;	$288	In Stock
25 mg	99.95% ;	$511	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

≥95%(HPLC)

$60

In Stock

5 mg

≥95%(HPLC)

$171

In Stock

10 mg

99.95% ;

$288

In Stock

25 mg

99.95% ;

$511

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	251565-85-2
Product Name	Tesaglitazar

Biological Targets

PPARA·PPARG

Associated Conditions

type 2 diabetes mellitus

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Tesaglitazar

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population.

Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.

Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar.

Documentation